AmacaThera
PrivateLast Round
Series A
Extension
Nov 28, 2023
Total Funding Raised
$14.7M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
AmacaThera is a biotechnology company that develops an injectable hydrogel platform for localized, sustained drug delivery to improve patient outcomes across multiple therapeutic areas.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Devices
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AmacaThera Comparables
Compare AmacaThera with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Allay Therapeutics | 88% | |
| AiViva BioPharma | 84% | |
| InSitu Biologics, Inc. | 83% | |
AmacaThera Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Nov 28, 2023 | ||||
| Series A | Feb 22, 2021 | ||||
| Seed | Oct 3, 2019 |
AmacaThera Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Grey Sky Venture Partners | Seed |
| Inveready | Series A, Series A Extension |
| MaRS Discovery District | Series A, Series A Extension |
| BDC Capital | Series A, Series A Extension |
| Viva BioInnovator | Series A |
| Viva Biotech | Seed |
| Lumira Ventures | Seed, Series A Extension, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors increased 2315% MoM, reaching 3.7K.
- Jun 26, 2026
Grew 27% QoQ from 15 to 19 employees.
AmacaThera Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about AmacaThera's valuation, stock price, and market status.